Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Physiol ; 266(1 Pt 2): H212-9, 1994 Jan.
Article in English | MEDLINE | ID: mdl-8304502

ABSTRACT

Interstitial exclusion, defined as the fraction of interstitial fluid volume inaccessible to a solute, was evaluated for immunoglobulin G (IgG) in selected tissues of rats by a method previously applied to serum albumin (29). IgG distribution volumes were also measured for intestine. 125I-labeled rat IgG was infused for 5 or 7 days (n = 4 rats each) with an implanted osmotic pump (Alzet). At the termination of infusion, the rat was anesthetized, nephrectomized, and injected with 51Cr-labeled EDTA (4 h) to label total extracellular fluid volume and 131I-labeled bovine IgG (5 min) to label plasma volume. Samples of skin, muscle, and tendon were assayed for total and extractable tracer activity. Interstitial fluid from these tissues was sampled postmortem with nylon wicks for assay of 125I-labeled IgG and endogenous albumin and IgG. Exclusion of IgG was calculated from the difference between extravascular 125I-labeled IgG and 51Cr-labeled EDTA distribution volumes. In contrast to our previous experience with tracer albumin, 125I-labeled IgG was not fully extractable from minced skin, muscle, or tendon by isotonic saline; only 71-83% was recovered under conditions that eluted 92-96% of tracer albumin and 94-99% of tracer EDTA. We conclude that approximately 20% of extravascular 125I-labeled IgG in these tissues is sequestered or bound in the interstitium. Calculation of IgG fractional exclusion from extractable tracer yielded the following values (means +/- SE, n = 8 rats): leg muscles 0.37 +/- 0.09, leg skin 0.44 +/- 0.03, back skin 0.36 +/- 0.04, tail skin 0.40 +/- 0.08, and tail tendon 0.55 +/- 0.04.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Extracellular Space/metabolism , Immunoglobulin G/metabolism , Animals , Homeostasis , Immunoglobulin G/blood , Iodine Radioisotopes , Male , Plasma , Rats , Rats, Wistar , Serum Albumin/metabolism , Tissue Distribution
2.
Am J Physiol ; 262(3 Pt 2): F333-7, 1992 Mar.
Article in English | MEDLINE | ID: mdl-1558152

ABSTRACT

In the nephrotic syndrome, the plasma level of some proteins of hepatic origin is partially defended by an increase in their synthetic rate. The plasma levels of several liver-derived proteins, as well as immunoglobulin G (IgG) are increased in one condition where plasma albumin concentration and oncotic pressure (II) are reduced, i.e., hereditary analbuminemia. To determine whether the urinary loss of IgG, a protein derived from the immune system, is compensated for by an increased synthetic rate, we measured IgG synthesis in normal Sprague-Dawley rats (SD); two models of the nephrotic syndrome: Heymann nephritis (HN) and Adriamycin treatment; and in Nagase analbuminemic rats (NAR), a model of decreased II without urinary protein loss. Plasma IgG and total IgG mass were significantly reduced in both HN and Adriamycin, yet IgG synthesis was nearly identical in HN, Adriamycin, and SD. In contrast, plasma and total IgG and IgG synthesis were all markedly increased in NAR. We derived a pathogen-free colony of NAR by Caesarean section and found that plasma IgG was not increased in pathogen-free NAR, despite reduced II. Thus, unlike proteins of hepatic origin (e.g., albumin) where synthesis increases following urinary loss, no compensatory increase in IgG synthesis occurs. Increased plasma IgG as well as IgG synthesis in the NAR is not a compensatory response to the absence of albumin or reduction in II, but rather is due to subclinical infection. Profound hypogammaglobulinemia of nephrotic syndrome occurs in part because no compensatory synthetic mechanisms balance urinary loss, and alteration in plasma II does not modulate IgG synthesis.


Subject(s)
Glomerulonephritis/blood , Immunoglobulin M/metabolism , Nephrotic Syndrome/blood , Serum Albumin/deficiency , Animals , Disease Models, Animal , Doxorubicin/toxicity , Glomerulonephritis/immunology , Glomerulonephritis/urine , Homeostasis , Immunoglobulin M/urine , Male , Nephrotic Syndrome/immunology , Nephrotic Syndrome/urine , Rats , Rats, Inbred Strains , Reference Values
3.
N Engl J Med ; 317(17): 1043-8, 1987 Oct 22.
Article in English | MEDLINE | ID: mdl-3309653

ABSTRACT

We investigated whether the anionic component of an orally administered sodium salt can influence the salt's capacity to increase blood pressure. In five men with essential hypertension in whom blood pressure was normal with restriction of dietary sodium chloride to 10 mmol per day (0.23 g of sodium per day), oral administration of sodium chloride for seven days, 240 mmol per day (5.52 g of sodium per day), induced significant increases in systolic and diastolic blood pressures, of 16 +/- 2 and 8 +/- 2 mm Hg (mean +/- SEM), respectively (P less than 0.05). An equimolar amount of sodium given as sodium citrate induced no change in blood pressure. Replacing supplemental sodium chloride with an equimolar amount of sodium as sodium citrate abolished the increase in blood pressure induced by sodium chloride. Both salts induced substantial and comparable sodium retention, weight gain, and suppression of plasma renin activity and plasma aldosterone, but supplemental sodium chloride increased plasma volume and urinary excretion of calcium, whereas sodium citrate did not. These preliminary findings demonstrate that the anionic component of an orally administered sodium salt can influence the ability of that salt to increase blood pressure, possibly by determining whether the salt induces an increase in plasma volume. Our observations in a small group of men with salt-sensitive hypertension will require confirmation in larger numbers of patients of both sexes.


Subject(s)
Blood Pressure/drug effects , Hypertension/physiopathology , Sodium Chloride/pharmacology , Sodium, Dietary/pharmacology , Aged , Aldosterone/blood , Body Weight/drug effects , Citrates/pharmacology , Citric Acid , Humans , Male , Middle Aged , Plasma Volume/drug effects , Renin/blood
4.
Kidney Int ; 30(6): 804-12, 1986 Dec.
Article in English | MEDLINE | ID: mdl-3102828

ABSTRACT

During the acute renal tubular dysfunction of Fanconi syndrome and type 2 renal tubular acidosis (FS/RTA2) induced by maleic acid in the unanesthetized dog, we observed: 30 minutes after the onset of FS/RTA2, the urinary excretion of lysosomal enzymes, N-acetyl-beta-glucosaminidase (NAG), beta-glucuronidase (beta-gluc) and beta-galactosidase (beta-galac), increased simultaneously with the anticipated increase in renal clearance of lysozyme; the severities of all these hyperenzymurias increased rapidly, progressively, and in parallel, all reaching a peak some 60 to 80 minutes after their onset; thereafter, while the FS/RTA2 continued undiminished in severity, the severity of the hyperenzymurias decreased rapidly, greatly, progressively, and in parallel; and sodium phosphate loading strikingly attenuated the FS/RTA2 and the hyperenzymurias. Thus, the maleic acid-induced FS/RTA2 is attended by an acute reversible-complex derangement in the renal tubular processing of proteins that: affects not only lysozyme which is normally filtered, but also NAG and other lysosomal enzymes, which are not; and is to some extent functionally separable from that of FS/RTA2. The findings suggest that the derangements in renal processing of lysozyme and lysosomal enzymes are linked, and that a phosphate-dependent metabolic abnormality in the proximal tubule can participate in the pathogenesis of both these derangements and the FS/RTA2.


Subject(s)
Acetylglucosaminidase/urine , Galactosidases/urine , Glucuronidase/urine , Hexosaminidases/urine , Kidney Diseases/urine , Maleates/pharmacology , Muramidase/urine , beta-Galactosidase/urine , Acidosis, Renal Tubular/chemically induced , Acidosis, Renal Tubular/enzymology , Acidosis, Renal Tubular/urine , Animals , Dogs , Fanconi Syndrome/chemically induced , Fanconi Syndrome/enzymology , Fanconi Syndrome/urine , Female , Injections, Intravenous , Kidney Diseases/chemically induced , Kidney Function Tests , Maleates/administration & dosage , Metabolic Clearance Rate , Phosphates/administration & dosage , Phosphates/metabolism
5.
Clin Chem ; 32(5): 782-6, 1986 May.
Article in English | MEDLINE | ID: mdl-3698269

ABSTRACT

We applied a sensitive, precise liquid-chromatographic method of analysis for inosine, hypoxanthine, and xanthine to the study of fructose metabolism in humans and in rats. In the rat, intravenous loading with fructose induced, within minutes, substantial increases in the concentrations of inosine, hypoxanthine, and xanthine in plasma and urine. In plasma, these concentrations peaked after 5 min, then practically disappeared within 10 min. As expected, the fructose-induced increase in hypoxanthine was greatly amplified by pretreating the rats with allopurinol, an inhibitor of xanthine oxidase. In a healthy human subject, intravenous administration of fructose also induced prompt, substantial, and rapidly reversing increases in the concentrations of these metabolites of adenine nucleotides in plasma. The finding that fructose induced almost-immediate increases in the plasma concentrations of inosine, hypoxanthine, and xanthine is consistent with previous studies in rats, in which parenteral administration of fructose induced almost-immediate decreases of total adenine nucleotides (ATP + ADP + AMP) in the liver, and increased concentrations of uric acid and allantoin in the plasma.


Subject(s)
Adenine Nucleotides/metabolism , Fructose/pharmacology , Hypoxanthines/analysis , Inosine/analysis , Xanthines/analysis , Allopurinol/pharmacology , Animals , Chromatography, Liquid/methods , Female , Fructose/administration & dosage , Humans , Hypoxanthine , Injections, Intravenous , Male , Rats , Rats, Inbred Strains , Time Factors , Xanthine
6.
Am J Physiol ; 243(6): F604-11, 1982 Dec.
Article in English | MEDLINE | ID: mdl-7149027

ABSTRACT

To investigate whether dysfunction of the proximal tubule underlies maleic acid-(MA) induced type II ("proximal") renal tubular acidosis (RTA II), we intravenously administered either MA or acetazolamide to eight conscious trained dogs undergoing water diuresis and examined the relationship between fractional solute-free water clearance (Ch2o/GFR), a measure of NaCl reabsorption in the post-proximal nephron, and either fractional urine flow (V/GFR), a measure of total solute rejected by the proximal tubule, or the sum of fractional excretion of Cl- and Ch2o/GFR [(Ccl + Ch2o)/GFR], a measure of proximally rejected solute that is potentially reabsorbable by the thick ascending limb. When MA or acetazolamide induced brisk bicarbonaturia at normal plasma bicarbonate concentrations: 1) V/GFR, (Ccl + Ch20)GFR, and Ch2o/GFR increased strikingly; 2) at any increment of Ch2o/GFR ws not; 3) the increments of V/GFR correlated positively with those of fractional excretion of bicarbonate (P less than 0.001); 4) during hyperchloremic acidosis, MA-induced bicarbonaturia was greatly attenuated; the increment in V/GFR was halved and approximated that in Ch20/GFR, which was unchanged; 5) when plasma bicarbonate was abruptly increased, bicarbonaturia increased strikingly and V/GFR increased further but Ch20/GFR and aminoaciduria did not. We conclude that MA induces a reduction in the net rate at which the proximal tubule reabsorbs HCO-3, Na+, and Cl-. This dysfunction underlies RTA II and evokes greatly increased reabsorption of Cl- and Na+ in the post-proximal tubule.


Subject(s)
Acidosis, Renal Tubular/physiopathology , Kidney Tubules, Proximal/physiopathology , Acetazolamide/pharmacology , Acidosis, Renal Tubular/chemically induced , Animals , Bicarbonates/blood , Diuresis/drug effects , Dogs , Female , Glomerular Filtration Rate , Maleates/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...